Insider filing · ELVN
Anish Patel
CHIEF OPERATING OFFICER
profile →
Enliven Therapeutics, Inc.
ELVN · Healthcare · 61 filings in 24 months
ticker →
Anish Patel sold $648K of Enliven Therapeutics (ELVN)
Executed Jan 7 2025, disclosed Jan 10 2025, 3 days later, against a two-business-day limit.
Value, as filed
$648K
26,837 sh across 2 lots
Executed
Jan 7 2025
the trade date, as filed
Disclosed
Jan 10 2025
3 days after the trade · past the deadline
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
APAnish Patel (CHIEF OPERATING OFFICER) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $1.3M of ELVN (48,057 sh × $27.98, as filed), executed Jan 9.
The name
ELVNHealthcare · Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibito…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Anish Patel in ELVN
ELVNSALE
Enliven Therapeutics, Inc.
$1.3M48,057 sh × $27.98
Exec Jan 9
Filed Jan 13 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. $103K
4,958 sh × $20.76
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. $105K
6,054 sh × $17.35
Exec Nov 7 2025
Filed Nov 12 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. $134K
6,667 sh × $20.10
Exec Oct 7 2025
Filed Oct 9 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. $135K
6,667 sh × $20.24
Exec Sep 8 2025
Filed Sep 10 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. $114K
6,262 sh × $18.20
Exec Aug 7 2025
Filed Aug 11 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. $126K
6,362 sh × $19.75
Exec Jul 7 2025
Filed Jul 9 2025 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. $134K
6,607 sh × $20.33
Exec Jun 9 2025
Filed Jun 11 2025 · 5:30 PM ET